Join the walk to cure Crohn’s and colitis
At walk sites across the country, thousands of people will gather to join the fight against digestive diseases. Together we’ll raise money for important research and raise awareness of two painful and unpredictable diseases that afflict millions of people.
Register today and take a step toward a future free from Crohn’s and colitis.
Find your local chapter by entering your zip code in the box to the left.
Adalimumab useful in Crohn's disease maintenance therapy
NEW YORK (Reuters Health) -- Subcutaneous administration of adalimumab is effective in treating Crohn's disease and in maintaining patients in clinical remission, according to findings of the CLASSIC II trial, reported in the September issue of Gut.
Read more.